Annals of the Rheumatic Diseases

SJR Rank #155H-index: 315SJR: 7.286Best quartile: Q1Open AccessAPC: US$4,870

Journal website: aims, scope and author guidelines

Publisher

Elsevier B.V.

Country

Netherlands

Type

journal

SJR by Edition

Subject Categories

Biochemistry, Genetics and Molecular Biology (miscellaneous)Q1
ImmunologyQ1
Immunology and AllergyQ1
RheumatologyQ1

Areas: Biochemistry, Genetics and Molecular Biology · Immunology and Microbiology · Medicine

Most published research topics

Rheumatoid Arthritis Research and TherapiesSystemic Lupus Erythematosus ResearchSpondyloarthritis Studies and TreatmentsSystemic Sclerosis and Related DiseasesAutoimmune and Inflammatory Disorders ResearchMonoclonal and Polyclonal Antibodies ResearchOsteoarthritis Treatment and MechanismsBone and Joint DiseasesImmunodeficiency and Autoimmune DisordersChronic Lymphocytic Leukemia Research

Source: OpenAlex

Publication Statistics

Documents per Year

Detailed Information

ISSN

0003-4967, 1468-2060

SJR Best Quartile

Region

Western Europe

Citations per Document (2 years)

11.22

References per Document

36.38

Coverage

1945-1948, 1950-2026

Scope

Annals of the Rheumatic Diseases (ARD) is an international peer review journal committed to promoting the highest standards of scientific exchange and education. It covers all aspects of rheumatology, which includes the spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research. Concise scientific communication is encouraged and peer reviewed proceedings of international meetings are featured. Educational papers include state of the art reviews, "how to" articles and educational cases that focus on problems faced in clinical practice. The journal was first published in 1939 and has an authorative global Editorial Board and a growing international readership.

Metrics from SCImago Journal Rank 2025. View on SCImago